Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors

NCT00385177 is registered in ClinicalTrials.gov with Achieve Life Sciences as lead sponsor.

NCT NCT00385177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00385177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors
Lead sponsor
Achieve Life Sciences
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2006
Completion date
May 31, 2009
Enrollment
61 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, colorectal neoplasms, lung neoplasms, pancreatic neoplasms, pelvic neoplasms